ORCHARD THERAPEUTICS PLC Accumulated Other Comprehensive Income
ORCHARD THERAPEUTICS PLC had Accumulated Other Comprehensive Income of $22.61 million as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2023-11-13
- 2023-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $22.61M.
- 2023-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $18.55M.
- 2023-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $20.36M.
- 2022-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $26.02M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2023-09-30 | $22.61M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $18.55M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $20.36M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $26.02M 10-Q · filed 2023-11-13 |
| 2022-09-30 | $47.57M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $26.03M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $8.58M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $3.25M 10-K · filed 2023-03-14 |
| 2021-09-30 | $3.73M 10-Q · filed 2021-11-04 |
| 2021-06-30 | -$186.00K 10-Q · filed 2021-08-04 |
| 2021-03-31 | $196.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $373.00K 10-K · filed 2022-03-30 |
| 2020-09-30 | $3.43M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $9.05M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $7.05M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $2.04M 10-K · filed 2021-03-02 |
| 2019-09-30 | $4.44M 6-K · filed 2019-11-07 |
| 2019-06-30 | $4.88M 6-K · filed 2019-08-08 |
| 2019-03-31 | $6.21M 6-K · filed 2019-05-28 |
| 2018-12-31 | $3.16M 10-K · filed 2020-02-27 |
| 2017-12-31 | $4.13M 20-F · filed 2019-03-22 |